Clinical Trial Update: Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I [NA]

View source ↗

Summary

An extension study of intrathecal enzyme replacement for cognitive decline in Mucopolysaccharidosis I has been terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Decline
• Mucopolysaccharidosis

Snippet

Sponsor: agnes chen | Conditions: Mucopolysaccharidosis I, Cognitive Decline | NA | Status: TERMINATED | Results posted: 2023-10-31